Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis
The Journal of Pathology · 2025
DOI: 10.1002/path.6376 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Pathology, 2025. Verfasst von Lydia A Schoenpflug und 25 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Deep Learning. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Medical Research Council, Wellcome Trust.
Abstract (Originalsprache)
Tumour content plays a pivotal role in directing the bioinformatic analysis of molecular profiles such as copy number variation (CNV). In clinical application, tumour purity estimation (TPE) is achieved either through visual pathological review [conventional pathology (CP)] or the deconvolution of molecular data. While CP provides a direct measurement, it demonstrates modest reproducibility and lacks standardisation. Conversely, deconvolution methods offer an indirect assessment with uncertain accuracy, underscoring the necessity for innovative approaches. SoftCTM is an open‐source, multiorgan deep‐learning (DL) model for the detection of tumour and non‐tumour cells in H&E‐stained slides, developed within the Overlapped Cell on Tissue Dataset for Histopathology (OCELOT) Challenge 2023. Here, using three large multicentre colorectal cancer (CRC) cohorts ( N = 1,097 patients) with digital pathology and multi‐omic data, we compare the utility and accuracy of TPE with SoftCTM versus CP and bioinformatic deconvolution methods (RNA expression, DNA methylation) for downstream molecular analysis, including CNV profiling. SoftCTM showed technical repeatability when applied twice on the same slide ( r = 1.0) and excellent correlations in paired H&E slides ( r > 0.9). TPEs profiled by SoftCTM correlated highly with RNA expression ( r = 0.59) and DNA methylation ( r = 0.40), while TPEs by CP showed a lower correlation with RNA expression ( r = 0.41) and DNA methylation ( r = 0.29). We show that CP and deconvolution methods respectively underestimate and overestimate tumour content compared to SoftCTM, resulting in 6–13% differing CNV calls. In summary, TPE with SoftCTM enables reproducibility, automation, and standardisation at single‐cell resolution. SoftCTM estimates ( M = 58.9%, SD ±16.3%) reconcile the overestimation by molecular data extrapolation (RNA expression: M = 79.2%, SD ±10.5, DNA methylation: M = 62.7%, SD ±11.8%) and underestimation by CP ( M = 35.9%, SD ±13.1%), providing a more reliable middle ground. A fully integrated computational pathology solution could therefore be used to improve downstream molecular analyses for research and clinics. © 2024 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Molecular Pathology, University Hospital and University of Zurich, Zurich, Switzerland.
- Wellcome Sanger Institute, Hinxton, UK.
- Institute of Biomedical Engineering (IBME), Department of Engineering Science, Old Road Campus Research Building, University of Oxford, Oxford, UK.
- Li Ka Shing Centre for Health Information and Discovery, Big Data Institute, University of Oxford, Oxford, UK.
- Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK.
- Ground Truth Labs Ltd, Oxford, UK.
ORCID-Profile: Lydia A Schoenpflug, Andrew Blake, Clare Verrill, Simon J Leedham, Philip Dunne, Andrew D Beggs, Philip Quirke
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Medical Research Council
- Wellcome Trust
- EPSRC Seebibyte programme
- NIHR Oxford Biomedical Research Centre
- CRUK and MRC
Zitieren
APA
Schoenpflug, L. A., Chatzipli, A., Sirinukunwattana, K., Richman, S., Blake, A., Robineau, J., Mertz, K. D., Verrill, C., Leedham, S. J., Hardy, C., Whalley, C., Redmond, K., Dunne, P., Walker, S., Beggs, A. D., McDermott, U., Murray, G. I., Samuel, L. M., Seymour, M., …, & Koelzer, V. H. (2025). Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis. The Journal of Pathology. https://doi.org/10.1002/path.6376
Vancouver
Schoenpflug LA, Chatzipli A, Sirinukunwattana K, Richman S, Blake A, Robineau J, et al. Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis. The Journal of Pathology. 2025. doi:10.1002/path.6376
BibTeX
@article{Schoenpflug2025,
author = {Schoenpflug, Lydia A and Chatzipli, Aikaterini and Sirinukunwattana, Korsuk and Richman, Susan and Blake, Andrew and Robineau, James and Mertz, Kirsten D and Verrill, Clare and Leedham, Simon J and Hardy, Claire and Whalley, Celina and Redmond, Keara and Dunne, Philip and Walker, Steven and Beggs, Andrew D and McDermott, Ultan and Murray, Graeme I and Samuel, Leslie M and Seymour, Matthew and Tomlinson, Ian and Quirke, Philip and S:CORT consortium, S:CORT consortium and Rittscher, Jens and Maughan, Tim and Domingo, Enric and Koelzer, Viktor H},
title = {Tumour purity assessment with deep learning in colorectal cancer and impact on molecular analysis},
journal = {The Journal of Pathology},
year = {2025},
doi = {10.1002/path.6376}
}
EUVIMED